COVID-19

News

Pandemic and currency headwinds hurt Roche in first half

Roche has announced half-year results showing the COVID-19 pandemic affected sales of its key products, with currency headwinds also weighing on revenues.

News

Controversy as pharma execs predict profits from COVID-19 va...

Concerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they expect to make profits from their products in evidence to a US

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

News

Healthware's New Normal resource hub for COVID-19

Healthware launches global resource hub for COVID-19’s 'new ...

Healthware has launched a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.

News

Pandemic hits sales at Novartis after strong launch for SMA ...

The COVID-19 pandemic has bit into sales at Novartis, the big Swiss pharma said in second quarter results, after orders fell back following a period of stockpiling earlier in the year.

News

Blood sample with respiratory coronavirus positive

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

The UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses if they check out in trials.

Pandemic and currency headwinds hurt Roche in first half

Controversy as pharma execs predict profits from COVID-19 va...

MSD’s David Peacock on moving UK healthcare forward

Healthware launches global resource hub for COVID-19’s 'new ...

Pandemic hits sales at Novartis after strong launch for SMA ...

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks